Altimmune (ALT) Other Non Operating Income (2010 - 2026)
Altimmune's (ALT) quarterly Other Non Operating Income came in at -$152000.0 in Q1 2026, down 1113.33% year-on-year from $15000.0 in Q1 2025, and down 109.61% on a QoQ basis from $1.6 million in Q4 2025.
Altimmune (ALT) Other Non Operating Income (2010 - 2026) Analysis & Trends
Altimmune (ALT) has 17 years of Other Non Operating Income data on file, last reported at -$152000.0 in Q1 2026.
- On a quarterly basis, Other Non Operating Income fell 1113.33% year-over-year to -$152000.0 in Q1 2026; TTM through Mar 2026 was $1.3 million, a 30.99% increase from a year earlier, with the FY2025 full-year figure at $1.4 million, up 52.8% from the prior year.
- Other Non Operating Income for Q1 2026 stood at -$152000.0, down from $1.6 million in the prior quarter.
- Over the last five years, Other Non Operating Income for ALT reached as high as $1.6 million in Q4 2025 and fell as low as -$217000.0 in Q4 2022.
- Historically, Other Non Operating Income has averaged $136941.2 across 5 years, with a median of $18000.0 in 2024.
- Across the five-year window, Other Non Operating Income soared 4890.0% in 2024 and plunged 1113.33% in 2026, its largest moves.
- Year by year, Other Non Operating Income stood at -$217000.0 in 2022, then surged by 109.22% to $20000.0 in 2023, then surged by 4890.0% to $998000.0 in 2024, then jumped by 58.42% to $1.6 million in 2025, then tumbled by 109.61% to -$152000.0 in 2026.
- Per Business Quant data, the three most recent Other Non Operating Income figures were -$152000.0 in Q1 2026, $1.6 million in Q4 2025, and -$86000.0 in Q3 2025.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Oculis Holding AG | 67,072.09 Bn | 67,072.09 Bn | - |
| 2 | Nanobiotix | 1,894.61 Bn | 1,894.55 Bn | - |
| 3 | Akari Therapeutics | 1,014.18 Bn | 1,014.18 Bn | - |
| 4 | BeOne Medicines | 471.64 Bn | 466.85 Bn | 1.35 Bn |
| 5 | Vertex Pharmaceuticals | 121.72 Bn | 114.47 Bn | 2.59 Bn |
| 6 | Regeneron Pharmaceuticals | 68.28 Bn | 59.52 Bn | 3.31 Bn |
| 7 | Belite Bio | 61.40 Bn | 61.40 Bn | - |
| 8 | Argenx Se | 56.94 Bn | 56.94 Bn | 1.18 Bn |
| 9 | Revolution Medicines | 37.37 Bn | 37.37 Bn | - |
| 10 | Altimmune | 346.63 Mn | 346.63 Mn | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | -152,000.00 |
| Dec 31, 2025 | 1.58 Mn |
| Sep 30, 2025 | -86,000.00 |
| Jun 30, 2025 | -92,000.00 |
| Mar 31, 2025 | 15,000.00 |
| Dec 31, 2024 | 998,000.00 |
| Sep 30, 2024 | 18,000.00 |
| Jun 30, 2024 | -76,000.00 |
| Mar 31, 2024 | -12,000.00 |
| Dec 31, 2023 | 20,000.00 |
| Sep 30, 2023 | 14,000.00 |
| Jun 30, 2023 | 113,000.00 |
| Mar 31, 2023 | 19,000.00 |
| Dec 31, 2022 | -217,000.00 |
| Sep 30, 2022 | 50,000.00 |
| Jun 30, 2022 | 25,000.00 |
| Mar 31, 2022 | 110,000.00 |
| Dec 31, 2021 | -81,000.00 |
| Sep 30, 2021 | -286,000.00 |
| Jun 30, 2021 | 26,000.00 |